Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3100
+0.0140 (4.73%)
Last updated: Oct 7, 2026, 8:16 PM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €33.01 million as of October 8, 2026. It is the 32,682nd most valuable company in the world and the 440th biggest in Germany. Its market cap has increased by 83.69% in one year.
Market Cap
33.01M
Enterprise Value
33.31M
Revenue
17.14K
Global Rank
Country Rank
#440 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 33.01M, an increase of 15.84%. That is a compound annual growth rate of 1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 33.01M | 1.33% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 86.40M |
| 2invest AG | 43.75M |
| Vidac Pharma Holding | 22.10M |
| Paion AG | 331.72K |
| bioXXmed AG | 277.30K |
| co.don AG | 213.79K |
| MagForce AG | 76.43K |